Open AccessPlatelet Count before Peripheral Blood Stem Cell Mobilization Is Associated with the Need for Plerixafor But Not with the Collection Result
Author(s) -
MarcAndrea Baertsch,
Katharina Kriegsmann,
Petra Pavel,
Thomas Brückner,
Michael Hundemer,
Mark Kriegsmann,
Anthony D. Ho,
Hartmut Goldschmidt,
Patrick Wuchter
Publication year - 2017
Publication title -
transfusion medicine and hemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 39
eISSN - 1660-3818
pISSN - 1660-3796
DOI - 10.1159/000478911
Subject(s) - plerixafor , medicine , multiple myeloma , mobilization , cd34 , population , autologous stem cell transplantation , platelet , apheresis , stem cell , cxcr4 , biology , genetics , chemokine , receptor , archaeology , history , environmental health
A low platelet count before mobilization has recurrently been identified as risk factor for poor mobilization.